A Phase 1, First-in-Human, Multi-Part Study of RAD140 in Postmenopausal Women With Hormone Receptor Positive Breast Cancer

What is the purpose of this trial?

The primary purpose of this study is to evaluate the clinical safety profile, tolerability, and pharmacokinetic (PK) characteristics of RAD140 in hormone receptor positive breast cancer.

Radius Pharmaceuticals, Inc.

Dates: 12/14/2017 - 12/01/2019

Last Updated: 02/22/2018

Study HIC#: 2000020658